Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin.

Batistatou A, Peschos D, Tsanou H, Charalabopoulos A, Nakanishi Y, Hirohashi S, Agnantis NJ, Charalabopoulos K.

Br J Cancer. 2007 May 7;96(9):1404-8. Epub 2007 Apr 17.

2.

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.

De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM.

J Pathol. 1997 Dec;183(4):404-11.

PMID:
9496256
3.

Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.

Palacios J, Benito N, Pizarro A, Suárez A, Espada J, Cano A, Gamallo C.

Am J Pathol. 1995 Mar;146(3):605-12.

4.

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.

Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ.

Am J Clin Pathol. 2001 Jan;115(1):85-98.

PMID:
11190811
5.

Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma.

Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ, Charalabopoulos K.

Virchows Arch. 2006 Jun;448(6):763-7. Epub 2006 Mar 29.

PMID:
16570180
6.

Involvement of dysadherin and E-cadherin in the development of testicular tumours.

Batistatou A, Scopa CD, Ravazoula P, Nakanishi Y, Peschos D, Agnantis NJ, Hirohashi S, Charalabopoulos KA.

Br J Cancer. 2005 Dec 12;93(12):1382-7.

7.

Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.

Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ.

Mod Pathol. 2003 Jul;16(7):674-8.

8.

Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Moll R, Mitze M, Frixen UH, Birchmeier W.

Am J Pathol. 1993 Dec;143(6):1731-42.

9.

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.

Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO.

Histopathology. 2005 Jun;46(6):685-93.

PMID:
15910600
10.

Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.

Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A.

Am J Pathol. 1993 Apr;142(4):987-93.

11.

Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression.

Shimamura T, Sakamoto M, Ino Y, Sato Y, Shimada K, Kosuge T, Sekihara H, Hirohashi S.

J Clin Oncol. 2003 Feb 15;21(4):659-67.

PMID:
12586803
13.

Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.

Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR.

J Pathol. 1993 Feb;169(2):245-50.

PMID:
8383197
14.

Altered expression of E-cadherin in breast cancer. patterns, mechanisms and clinical significance.

Asgeirsson KS, Jónasson JG, Tryggvadóttir L, Olafsdóttir K, Sigurgeirsdóttir JR, Ingvarsson S, Ogmundsdóttir HM.

Eur J Cancer. 2000 Jun;36(9):1098-106.

PMID:
10854942
15.

Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis.

Maluf HM, Swanson PE, Koerner FC.

Am J Surg Pathol. 2001 Feb;25(2):237-44.

PMID:
11176073
16.

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.

Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Valgeirsson H, Lambros M, Ashworth A, Palacios J, Schmitt F, Lakhani SR.

J Pathol. 2005 Sep;207(1):1-13.

PMID:
15957152
18.

Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.

Kuroda H, Tamaru J, Takeuchi I, Ohnisi K, Sakamoto G, Adachi A, Kaneko K, Itoyama S.

Virchows Arch. 2006 Apr;448(4):500-5. Epub 2006 Mar 15.

PMID:
16538444
19.

Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.

Rieger-Christ KM, Pezza JA, Dugan JM, Braasch JW, Hughes KS, Summerhayes IC.

Mol Pathol. 2001 Apr;54(2):91-7.

20.

Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.

Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M.

Am J Surg Pathol. 2007 Jan;31(1):85-94.

PMID:
17197923

Supplemental Content

Support Center